Written by Amy Neuer, Applied Clinical Trials
Antibody treatments could be a bridge to a vaccine Written by Karin Brulliard and Carolyn Y. Johnson...
Interview with Daniel Levine, The Bio Report One of the challenges to securing the participation of ...
Written by Catheine Ho, San Francisco Chronicle
Brian Neman, CEO and co-founder of Sanguine Biosciences, is bringing the clinical trial into the hom...
Acquiring samples from patients within the comfort of their own homes could help clinical trials mov...
Written by Jonathan Saltzman, The Boston Globe
Written by Gary Robbins, San Diego Tribune